Antibiotic Guidelines

Chapter 5: Antibiotic Prophylaxis for Surgical Procedures

Antibiotic Guidelines
Chapter 5: Antibiotic Prophylaxis for Surgical Procedures
Read Document

Introduction

Surgical site infections (SSIs) are a major cause of healthcare-associated infections. The CDC defines an SSI as an infection related to an operative procedure occurring at or near the surgical incision within 30 days, or within 90 days if a prosthesis is implanted.

Despite clear evidence and guidelines, prophylactic antibiotic use remains inconsistent — often involving incorrect choice, timing, or duration.

Fundamental Principles of Surgical Prophylaxis

  • Goal: prevent SSIs by reducing bacterial burden during surgery.
  • Antibiotics must be present in tissue at time of incision.
  • Single-dose prophylaxis is typically sufficient.
  • Repeat dosing only if surgery >2 drug half-lives or >1500 mL blood loss.
  • Choose antibiotic based on expected pathogens.
  • High-risk patients (e.g., diabetics, prosthesis insertions) benefit most.
  • Good surgical technique is key.
  • First-generation cephalosporins are often preferred.
  • Cephalosporins generally safe despite reported penicillin allergies.

Timing of Administration

  • Administer 30–60 min before incision.
  • Vancomycin and fluoroquinolones require earlier infusion (~2 hrs pre-op).
  • Delayed administration increases SSI risk 6-fold.
  • Anaesthetist should ideally administer in theatre.

Route of Administration

  • All antibiotics unless otherwise stated are given IV.
  • Oral agents used only for elective colon or high-risk urological procedures.

Indications for Prophylaxis

Prophylaxis is recommended for:

  • Clean-contaminated procedures (e.g., controlled GI tract entry).
  • Clean surgeries involving prosthetics or high-risk areas (e.g., breast, hernia).
  • Not for contaminated or dirty procedures — these require treatment.

Surgical Prophylaxis Summary

Surgical Procedure Common Pathogens Recommended Antibiotic Dose & Route
Cardiothoracic Staphylococci Cefazolin or Cefuroxime 2 g IV or 1.5 g IV
Vascular (non-cardiac) Staphylococci Cefazolin or Amoxicillin/clavulanate 2 g IV or 1.2 g IV
Joint replacement Staphylococci Cefazolin 2 g IV
Appendectomy Coliforms, Bacteroides Cefazolin + Metronidazole OR Cefoxitin 2 g IV + 500 mg IV or 2 g IV
Colon surgery Coliforms, anaerobes Cefazolin + Metronidazole OR Amox/clav 2 g + 500 mg IV or 1.2 g IV
Caesarean (emergency) Mixed flora Cefazolin 2 g IV
Urology with GI entry Coliforms, anaerobes Cefazolin + Metronidazole OR Cefoxitin 2 g IV + 500 mg IV or 2 g IV
Prostate biopsy Coliforms Ciprofloxacin 500 mg PO

Additional Notes

  • For MRSA risk: Vancomycin 15 mg/kg IV or Teicoplanin 400–800 mg.
  • For beta-lactam allergy:
    • Use Clindamycin 900 mg IV ± Gentamicin or Ciprofloxacin depending on procedure.
  • Cefazolin 3 g IV for patients >120 kg.
  • No prophylaxis for tonsillectomy, adenoidectomy, or clean head/neck procedures.